Literature DB >> 21570093

Complete removal as a routine treatment for any cardiovascular implantable electronic device-associated infection.

Maximilian Pichlmaier1, Ludmilla Knigina, Ingo Kutschka, Christoph Bara, Hanno Oswald, Gunnar Klein, Theodosius Bisdas, Axel Haverich.   

Abstract

OBJECTIVE: Pacemaker and implantable cardioverter defibrillator lead endocarditis mandates removal of all foreign material. In supposedly limited (pocket) infections, such a radical approach is still controversial. Thus, some patients are potentially exposed to persistent and recurrent infection because of retained material. Procedural risks and the success of eradicating infection were examined if involvement of the complete system was assumed in any cardiovascular implantable electronic device infection and complete removal was thus mandatory.
METHODS: A 12-year experience with 192 consecutive cases of bacterial pacemaker (152) or defibrillator (40) infections is presented. Complete removal of all prosthetic material was always aimed for. This was followed by antibiotic treatment for 4 to 6 weeks under temporary pacing if required, and then the new system was implanted. A total of 104 parameters concerning patient characteristics and operative and postoperative treatment were examined for their influence on outcome.
RESULTS: Infection was eradicated in 92.8% of patients. Recurrence was predominantly caused by failure to remove all prosthetic material (P < .001). If the protocol was strictly followed, infection was eradicated in 97.4% of patients. Conversely, 71.4% of patients with retained material showed recurrence. Further risk factors were poor dental hygiene and evidence of chronic subclinical infection. Morbidity and mortality of the interventional and open procedures were low. Open lead extraction was performed primarily in 34 patients (17.7%) and secondarily in 3 patients (1.9%). Temporary pacing and long-term antibiotic treatment were well tolerated.
CONCLUSIONS: Complete removal of prosthetic material in any cardiovascular implantable electronic device infection is safe and associated with low morbidity and mortality. Success of eradicating infection is high if all system components are removed. Temporary pacing in dependent patients may be performed safely on an outpatient basis.
Copyright © 2011 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21570093     DOI: 10.1016/j.jtcvs.2010.11.059

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  11 in total

1.  Complete removal of infected devices and simultaneous implantation of new devices for infective endocarditis after pacemaker implantation.

Authors:  Takuya Miura; Kazushige Inoue; Takenori Yokota; Takashi Iwata; Masao Yoshitatsu
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-07-31

2.  Management of Cardiac Electronic Device Infections: Challenges and Outcomes.

Authors:  Rikke Esberg Kirkfeldt; Jens Brock Johansen; Jens Cosedis Nielsen
Journal:  Arrhythm Electrophysiol Rev       Date:  2016

3.  Long-term outcome of complete cardiovascular implantable electronic device removal with cardiopulmonary bypass.

Authors:  Masaho Okada; Yuji Narita; Yoshimori Araki; Hideki Oshima; Akihiko Usui; Yuichi Ueda
Journal:  J Artif Organs       Date:  2013-01-20       Impact factor: 1.731

4.  Snare sheath versus evolution sheath in transvenous lead extraction.

Authors:  Jihua Kong; Yilun Tian; Fei Guo; Feng Ze; Jiangbo Duan; Long Wang; Xuebin Li; Jihong Guo
Journal:  Int J Clin Exp Med       Date:  2015-11-15

5.  Fistula Formation 6 Years after Removal of Infected Pacemaker Leads.

Authors:  Thomas Schroeter; Philipp Kiefer; Matthias Sauer; Friedrich Wilhelm Mohr
Journal:  Thorac Cardiovasc Surg Rep       Date:  2015-02-17

6.  Lead extractions in patients with cardiac implantable electronic device infections: Single center experience.

Authors:  Masahiko Goya; Michio Nagashima; Ken-Ichi Hiroshima; Kentaro Hayashi; Yu Makihara; Masato Fukunaga; Yoshimori An; Masatsugu Ohe; So-Ichiro Yamazato; Ko-Ichiro Sonoda; Kennosuke Yamashita; Kouji Katayama; Tomoaki Ito; Harushi Niu; Kenji Ando; Hiroyoshi Yokoi; Masashi Iwabuchi
Journal:  J Arrhythm       Date:  2016-03-22

7.  Primary Cardiac B-Non-Hodgkin Lymphoma Disguised as a Pacemaker Endocarditis.

Authors:  Felix Fleißner; Ulrich Molitoris; Wiebke Rösler; Christian Kühn
Journal:  Thorac Cardiovasc Surg Rep       Date:  2018-06-28

8.  A non-conventional approach to 10-year-delayed extraction of pacemaker leads associated with recurrent infective complications.

Authors:  Nicolae Dan Tesloianu; Andreea Mihaela Ignat; Dana Corduneanu; Antoniu Octavian Petris; Ionut Tudorancea
Journal:  Anatol J Cardiol       Date:  2017-10       Impact factor: 1.596

9.  Percutaneous Lead Extraction in Infection of Cardiac Implantable Electronic Devices: a Systematic Review.

Authors:  Antônio da Silva Menezes Júnior; Thaís Rodrigues Magalhães; Alana de Oliveira Alarcão Morais
Journal:  Braz J Cardiovasc Surg       Date:  2018 Mar-Apr

10.  Delayed Improvement of Left Ventricular Function in Newly Diagnosed Heart Failure Depends on Etiology-A PROLONG-II Substudy.

Authors:  Johanna Mueller-Leisse; Johanna Brunn; Christos Zormpas; Stephan Hohmann; Henrike Aenne Katrin Hillmann; Jörg Eiringhaus; Johann Bauersachs; Christian Veltmann; David Duncker
Journal:  Sensors (Basel)       Date:  2022-03-05       Impact factor: 3.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.